Clusterin glycopeptide variant characterization reveals significant site-specific glycan changes in the plasma of clear cell renal cell carcinoma

Journal of Proteome Research

Volumn 14, Issue 6, 2015, Pages 2425-2436

  Gbormittah, Francisca O ^a   Bones, Jonathan ^b   Hincapie, Marina ^c   Tousi, Fateme ^a   Hancock, William S ^a   Iliopoulos, Othon ^d,e  

^a NORTHEASTERN UNIVERSITY   (United States)

^b NATIONAL INSTITUTE FOR BIOPROCESSING RESEARCH AND TRAINING   (Ireland)

^c SANOFI   (France)

^d MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Clear cell renal cell carcinoma; clusterin; collision induced dissociation; glycoforms; N glycan; site specific analysis

Indexed keywords

CLUSTERIN; GLYCAN; GLYCOPEPTIDE; LECTIN; POLYSACCHARIDE;

ADULT; ARTICLE; BLOOD SAMPLING; BLOTTING; CANCER PATIENT; CANCER SURGERY; CLINICAL ARTICLE; COLLISIONALLY ACTIVATED DISSOCIATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KIDNEY CARCINOMA; LECTIN BLOTTING; LIQUID CHROMATOGRAPHY; MALE; MIDDLE AGED; NEPHRECTOMY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; TANDEM MASS SPECTROMETRY; AFFINITY CHROMATOGRAPHY; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY TUMOR; METABOLISM; PATHOLOGY; REPRODUCIBILITY;

CARCINOMA, RENAL CELL; CHROMATOGRAPHY, AFFINITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLUSTERIN; GLYCOPEPTIDES; HUMANS; KIDNEY NEOPLASMS; POLYSACCHARIDES; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY;

EID: 84930606343     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr501104j     Document Type: Article

References (65)

1. Weiss, R. H.; Lin, P. Y. Kidney cancer: identification of novel targets for therapy Kidney Int. 2006, 69, 224-32
2. Pantuck, A. J.; Zisman, A.; Belldegrun, A. S. The changing natural history of renal cell carcinoma J. Urol. 2001, 166, 1611-23
3. Yurist-Doutsch, S.; Chaban, B.; VanDyke, D. J.; Jarrell, K. F.; Eichler, J. Sweet to the extreme: protein glycosylation in Archaea Mol. Microbiol. 2008, 68, 1079-84
4. Freeze, H. H. Congenital disorders of glycosylation: CDG-I, CDG-II, and beyond Curr. Mol. Med. 2007, 7, 389-96
5. Vigerust, D. J.; Shepherd, V. L. Virus glycosylation: role in virulence and immune interactions Trends Microbiol. 2007, 15, 211-8
6. Rambaruth, N. D.; Dwek, M. V. Cell surface glycan-lectin interactions in tumor metastasis Acta Histochem. 2011, 113, 591-600
7. Meany, D. L.; Zhang, Z.; Sokoll, L. J.; Zhang, H.; Chan, D. W. Glycoproteomics for prostate cancer detection: changes in serum PSA glycosylation patterns J. Proteome Res. 2009, 8, 613-9
8. Hammarstrom, S. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues Semin. Cancer Biol. 1999, 9, 67-81
9. Moss, E. L.; Hollingworth, J.; Reynolds, T. M. The role of CA125 in clinical practice J. Clin. Pathol. 2005, 58, 308-12
10. Poon, T. C.; Mok, T. S.; Chan, A. T.; Chan, C. M.; Leong, V.; Tsui, S. H.; Leung, T. W.; Wong, H. T.; Ho, S. K.; Johnson, P. J. Quantification and utility of monosialylated alpha-fetoprotein in the diagnosis of hepatocellular carcinoma with nondiagnostic serum total alpha-fetoprotein Clin. Chem. 2002, 48, 1021-7
11. Meany, D. L.; Chan, D. W. Aberrant glycosylation associated with enzymes as cancer biomarkers Clin. Proteomics 2011, 8, 7
12. Bones, J.; McLoughlin, N.; Hilliard, M.; Wynne, K.; Karger, B. L.; Rudd, P. M. 2D-LC analysis of BRP 3 erythropoietin N-glycosylation using anion exchange fractionation and hydrophilic interaction UPLC reveals long poly- N -acetyl lactosamine extensions Anal. Chem. 2011, 83, 4154-62
13. Deshpande, N.; Jensen, P. H.; Packer, N. H.; Kolarich, D. GlycoSpectrumScan: fishing glycopeptides from MS spectra of protease digests of human colostrum sIgA J. Proteome Res. 2010, 9, 1063-75
14. Lee, A.; Chick, J. M.; Kolarich, D.; Haynes, P. A.; Robertson, G. R.; Tsoli, M.; Jankova, L.; Clarke, S. J.; Packer, N. H.; Baker, M. S. Liver membrane proteome glycosylation changes in mice bearing an extra-hepatic tumor Mol. Cell. Proteomics 2011, 10, M900538-MCP200
15. Lee, A.; Nakano, M.; Hincapie, M.; Kolarich, D.; Baker, M. S.; Hancock, W. S.; Packer, N. H. The lectin riddle: glycoproteins fractionated from complex mixtures have similar glycomic profiles OMICS 2010, 14, 487-99
16. Nakano, M.; Nakagawa, T.; Ito, T.; Kitada, T.; Hijioka, T.; Kasahara, A.; Tajiri, M.; Wada, Y.; Taniguchi, N.; Miyoshi, E. Site-specific analysis of N-glycans on haptoglobin in sera of patients with pancreatic cancer: a novel approach for the development of tumor markers Int. J. Cancer 2008, 122, 2301-9
17. Nwosu, C. C.; Seipert, R. R.; Strum, J. S.; Hua, S. S.; An, H. J.; Zivkovic, A. M.; German, B. J.; Lebrilla, C. B. Simultaneous and extensive site-specific N- and O-glycosylation analysis in protein mixtures J. Proteome Res. 2011, 10, 2612-24
18. Pompach, P.; Chandler, K. B.; Lan, R.; Edwards, N.; Goldman, R. Semi-automated identification of N-glycopeptides by hydrophilic interaction chromatography, nano-reverse-phase LC-MS/MS, and glycan database search J. Proteome Res. 2012, 11, 1728-40
19. Jensen, P. H.; Karlsson, N. G.; Kolarich, D.; Packer, N. H. Structural analysis of N- and O-glycans released from glycoproteins Nat. Protoc. 2012, 7, 1299-310
20. Du, M. Q.; Hutchinson, W. L.; Johnson, P. J.; Williams, R. Differential alpha-fetoprotein lectin binding in hepatocellular carcinoma. Diagnostic utility at low serum levels Cancer 1991, 67, 476-80
21. Taketa, K.; Sekiya, C.; Namiki, M.; Akamatsu, K.; Ohta, Y.; Endo, Y.; Kosaka, K. Lectin-reactive profiles of alpha-fetoprotein characterizing hepatocellular carcinoma and related conditions Gastroenterology 1990, 99, 508-18
22. Sterling, R. K.; Jeffers, L.; Gordon, F.; Sherman, M.; Venook, A. P.; Reddy, K. R.; Satomura, S.; Schwartz, M. E. Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis Am. J. Gastroenterol. 2007, 102, 2196-205
23. Kolarich, D.; Jensen, P. H.; Altmann, F.; Packer, N. H. Determination of site-specific glycan heterogeneity on glycoproteins Nat. Protoc. 2012, 7, 1285-98
24. Hua, S.; Nwosu, C. C.; Strum, J. S.; Seipert, R. R.; An, H. J.; Zivkovic, A. M.; German, J. B.; Lebrilla, C. B. Site-specific protein glycosylation analysis with glycan isomer differentiation Anal. Bioanal. Chem. 2012, 403, 1291-302
25. Hua, S.; Lebrilla, C.; An, H. J. Application of nano-LC-based glycomics towards biomarker discovery Bioanalysis 2011, 3, 2573-85
26. Wang, D.; Hincapie, M.; Rejtar, T.; Karger, B. L. Ultrasensitive characterization of site-specific glycosylation of affinity-purified haptoglobin from lung cancer patient plasma using 10 mum i.d. porous layer open tubular liquid chromatography-linear ion trap collision-induced dissociation/electron transfer dissociation mass spectrometry Anal. Chem. 2011, 83, 2029-37
27. Blaschuk, O.; Burdzy, K.; Fritz, I. B. Purification and characterization of a cell-aggregating factor (clusterin), the major glycoprotein in ram rete testis fluid J. Biol. Chem. 1983, 258, 7714-20
28. Chen, X.; Halberg, R. B.; Ehrhardt, W. M.; Torrealba, J.; Dove, W. F. Clusterin as a biomarker in murine and human intestinal neoplasia Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 9530-5
29. Miyake, H.; Gleave, M. E.; Arakawa, S.; Kamidono, S.; Hara, I. Introducing the clusterin gene into human renal cell carcinoma cells enhances their metastatic potential J. Urol. 2002, 167, 2203-8
30. Redondo, M.; Villar, E.; Torres-Munoz, J.; Tellez, T.; Morell, M.; Petito, C. K. Overexpression of clusterin in human breast carcinoma Am. J. Pathol. 2000, 157, 393-9
31. Steinberg, J.; Oyasu, R.; Lang, S.; Sintich, S.; Rademaker, A.; Lee, C.; Kozlowski, J. M.; Sensibar, J. A. Intracellular levels of SGP-2 (clusterin) correlate with tumor grade in prostate cancer Clin. Cancer Res. 1997, 3, 1707-11
32. Xie, D.; Lau, S. H.; Sham, J. S.; Wu, Q. L.; Fang, Y.; Liang, L. Z.; Che, L. H.; Zeng, Y. X.; Guan, X. Y. Up-regulated expression of cytoplasmic clusterin in human ovarian carcinoma Cancer 2005, 103, 277-83
33. Nakamura, E.; Abreu-e-Lima, P.; Awakura, Y.; Inoue, T.; Kamoto, T.; Ogawa, O.; Kotani, H.; Manabe, T.; Zhang, G. J.; Kondo, K.; Nose, V.; Kaelin, W. G., Jr. Clusterin is a secreted marker for a hypoxia-inducible factor-independent function of the von Hippel-Lindau tumor suppressor protein Am. J. Pathol. 2006, 168, 574-84
34. Kurahashi, T.; Muramaki, M.; Yamanaka, K.; Hara, I.; Miyake, H. Expression of the secreted form of clusterin protein in renal cell carcinoma as a predictor of disease extension BJU Int. 2005, 96, 895-9
35. Tousi, F.; Bones, J.; Iliopoulos, O.; Hancock, W. S.; Hincapie, M. Multidimensional liquid chromatography platform for profiling alterations of clusterin N-glycosylation in the plasma of patients with renal cell carcinoma J. Chromatogr. A 2012, 1256, 121-8
36. Damerell, D.; Ceroni, A.; Maass, K.; Ranzinger, R.; Dell, A.; Haslam, S. M. The GlycanBuilder and GlycoWorkbench glycoinformatics tools: updates and new developments Biol. Chem. 2012, 393, 1357-62
37. Jenne, D. E.; Tschopp, J. Clusterin: the intriguing guises of a widely expressed glycoprotein Trends Biochem. Sci. 1992, 17, 154-9
38. Wuhrer, M.; Catalina, M. I.; Deelder, A. M.; Hokke, C. H. Glycoproteomics based on tandem mass spectrometry of glycopeptides J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2007, 849, 115-28
39. Wada, Y.; Azadi, P.; Costello, C. E.; Dell, A.; Dwek, R. A.; Geyer, H.; Geyer, R.; Kakehi, K.; Karlsson, N. G.; Kato, K.; Kawasaki, N.; Khoo, K. H.; Kim, S.; Kondo, A.; Lattova, E.; Mechref, Y.; Miyoshi, E.; Nakamura, K.; Narimatsu, H.; Novotny, M. V.; Packer, N. H.; Perreault, H.; Peter-Katalinic, J.; Pohlentz, G.; Reinhold, V. N.; Rudd, P. M.; Suzuki, A.; Taniguchi, N. Comparison of the methods for profiling glycoprotein glycans-HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study Glycobiology 2007, 17, 411-22
40. Stavenhagen, K.; Hinneburg, H.; Thaysen-Andersen, M.; Hartmann, L.; Varón Silva, D.; Fuchser, J.; Kaspar, S.; Rapp, E.; Seeberger, P. H.; Kolarich, D. Quantitative mapping of glycoprotein micro-heterogeneity and macro-heterogeneity: an evaluation of mass spectrometry signal strengths using synthetic peptides and glycopeptides J. Mass Spectrom. 2013, 48, 627-39
41. Chen, R.; Jiang, X.; Sun, D.; Han, G.; Wang, F.; Ye, M.; Wang, L.; Zou, H. Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry J. Proteome Res. 2009, 8, 651-61
42. Huddleston, M. J.; Bean, M. F.; Carr, S. A. Collisional fragmentation of glycopeptides by electrospray ionization LC/MS and LC/MS/MS: methods for selective detection of glycopeptides in protein digests Anal. Chem. 1993, 65, 877-84
43. Sullivan, B.; Addona, T. A.; Carr, S. A. Selective detection of glycopeptides on ion trap mass spectrometers Anal. Chem. 2004, 76, 3112-8
44. Cooper, C. A.; Gasteiger, E.; Packer, N. H. GlycoMod-a software tool for determining glycosylation compositions from mass spectrometric data Proteomics 2001, 1, 340-9
45. Conboy, J. J.; Henion, J. D. The determination of glycopeptides by liquid chromatography/mass spectrometry with collision-induced dissociation J. Am. Soc. Mass Spectrom. 1992, 3, 804-14
46. Hunter, A. P.; Games, D. E. Evaluation of glycosylation site heterogeneity and selective identification of glycopeptides in proteolytic digests of bovine alpha 1-acid glycoprotein by mass spectrometry Rapid Commun. Mass Spectrom. 1995, 9, 42-56
47. Tschopp, J.; French, L. E. Clusterin: modulation of complement function Clin. Exp. Immunol. 1994, 97, 11-4
48. Shannan, B.; Seifert, M.; Leskov, K.; Willis, J.; Boothman, D.; Tilgen, W.; Reichrath, J. Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer Cell Death Differ. 2006, 13, 12-9
49. Zoubeidi, A.; Ettinger, S.; Beraldi, E.; Hadaschik, B.; Zardan, A.; Klomp, L. W.; Nelson, C. C.; Rennie, P. S.; Gleave, M. E. Clusterin facilitates COMMD1 and I-kappaB degradation to enhance NF-kappaB activity in prostate cancer cells Mol. Cancer Res. 2010, 8, 119-30
50. Laslop, A.; Steiner, H. J.; Egger, C.; Wolkersdorfer, M.; Kapelari, S.; Hogue-Angeletti, R.; Erickson, J. D.; Fischer-Colbrie, R.; Winkler, H. Glycoprotein III (clusterin, sulfated glycoprotein 2) in endocrine, nervous, and other tissues: immunochemical characterization, subcellular localization, and regulation of biosynthesis J. Neurochem. 1993, 61, 1498-505
51. Trougakos, I. P.; Gonos, E. S. Clusterin/apolipoprotein J in human aging and cancer Int. J. Biochem. Cell Biol. 2002, 34, 1430-48
52. Arnold, J. N.; Saldova, R.; Galligan, M. C.; Murphy, T. B.; Mimura-Kimura, Y.; Telford, J. E.; Godwin, A. K.; Rudd, P. M. Novel glycan biomarkers for the detection of lung cancer J. Proteome Res. 2011, 10, 1755-64
53. Tabarés, G.; Radcliffe, C. M.; Barrabes, S.; Ramirez, M.; Aleixandre, R. N.; Hoesel, W.; Dwek, R. A.; Rudd, P. M.; Peracaula, R.; de Llorens, R. Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA Glycobiology 2006, 16, 132-45
54. Everest-Dass, A. V.; Abrahams, J. L.; Kolarich, D.; Packer, N. H.; Campbell, M. P. Structural feature ions for distinguishing N- and O- linked glycan isomers by LC-ES-IT-MS/MS J. Am. Soc. Mass Spectrom. 2013, 24, 895-906
55. Everest-Dass, A. V.; Kolarich, D.; Campbell, M. P.; Packer, N. H. Tandem mass spectra of glycan structures enable the multistage mass spectrometric identification of determinants on oligosaccharides Rapid Commin. Mass Spectrom. 2013, 27, 931-9
56. Miyoshi, E.; Noda, K.; Yamaguchi, Y.; Inoue, S.; Ikeda, Y.; Wang, W.; Ko, J. H.; Uozumi, N.; Li, W.; Taniguchi, N. The alpha1-6-fucosyltransferase gene and its biological significance Biochim. Biophys. Acta 1999, 1473, 9-20
57. Santer, U. V.; Glick, M. C. Partial structure of a membrane glycopeptide from virus-transformed hamster cells Biochemistry 1979, 18, 2533-40
58. Okuyama, N.; Ide, Y.; Nakano, M.; Nakagawa, T.; Yamanaka, K.; Moriwaki, K.; Murata, K.; Ohigashi, H.; Yokoyama, S.; Eguchi, H.; Ishikawa, O.; Ito, T.; Kato, M.; Kasahara, A.; Kawano, S.; Gu, J.; Taniguchi, N.; Miyoshi, E. Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation Int. J. Cancer 2006, 118, 2803-8
59. Nakagawa, T.; Uozumi, N.; Nakano, M.; Mizuno-Horikawa, Y.; Okuyama, N.; Taguchi, T.; Gu, J.; Kondo, A.; Taniguchi, N.; Miyoshi, E. Fucosylation of N-glycans regulates the secretion of hepatic glycoproteins into bile ducts J. Biol. Chem. 2006, 281, 29797-806
60. Sarrats, A.; Saldova, R.; Comet, J.; ODonoghue, N.; de Llorens, R.; Rudd, P. M.; Peracaula, R. Glycan characterization of PSA 2-DE subforms from serum and seminal plasma OMICS 2010, 14, 465-74
61. White, K. Y.; Rodemich, L.; Nyalwidhe, J. O.; Comunale, M. A.; Clements, M. A.; Lance, R. S.; Schellhammer, P. F.; Mehta, A. S.; Semmes, O. J.; Drake, R. R. Glycomic characterization of prostate-specific antigen and prostatic acid phosphatase in prostate cancer and benign disease seminal plasma fluids J. Proteome Res. 2009, 8, 620-30
62. Orchekowski, R.; Hamelinck, D.; Li, L.; Gliwa, E.; vanBrocklin, M.; Marrero, J. A.; Vande Woude, G. F.; Feng, Z.; Brand, R.; Haab, B. B. Antibody microarray profiling reveals individual and combined serum proteins associated with pancreatic cancer Cancer Res. 2005, 65, 11193-202
63. Patwa, T. H.; Zhao, J.; Anderson, M. A.; Simeone, D. M.; Lubman, D. M. Screening of glycosylation patterns in serum using natural glycoprotein microarrays and multi-lectin fluorescence detection Anal. Chem. 2006, 78, 6411-21
64. Qiu, Y.; Patwa, T. H.; Xu, L.; Shedden, K.; Misek, D. E.; Tuck, M.; Jin, G.; Ruffin, M. T.; Turgeon, D. K.; Synal, S.; Bresalier, R.; Marcon, N.; Brenner, D. E.; Lubman, D. M. Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot J. Proteome Res. 2008, 7, 1693-703
65. Zhao, J.; Patwa, T. H.; Qiu, W.; Shedden, K.; Hinderer, R.; Misek, D. E.; Anderson, M. A.; Simeone, D. M.; Lubman, D. M. Glycoprotein microarrays with multi-lectin detection: unique lectin binding patterns as a tool for classifying normal, chronic pancreatitis and pancreatic cancer sera J. Proteome Res. 2007, 6, 1864-74